reboxetine has been researched along with Learning Disabilities in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chiu, GS; Freund, GG; Gainey, SJ; Kaczmarczyk, MM; Kelley, KW; Kwakwa, KA; Lawson, MA; Machaj, AS; Martin, SA; Meling, DD; Miller, MJ; Newman, AF; Wang, Y; Woods, JA; York, JM | 1 |
Bhagya, V; Raju, TR; Shankaranarayana Rao, BS; Srikumar, BN | 1 |
2 other study(ies) available for reboxetine and Learning Disabilities
Article | Year |
---|---|
Methylphenidate prevents high-fat diet (HFD)-induced learning/memory impairment in juvenile mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antidepressive Agents; Anxiety; Blood Glucose; Body Weight; Brain-Derived Neurotrophic Factor; Central Nervous System Stimulants; Cerebral Cortex; Cytokines; Desipramine; Dietary Fats; Dopamine; Exploratory Behavior; Gene Expression Regulation; Hippocampus; Homovanillic Acid; Indoleamine-Pyrrole 2,3,-Dioxygenase; Learning Disabilities; Male; Maze Learning; Memory Disorders; Methylphenidate; Mice; Mice, Knockout; Monoamine Oxidase; Morpholines; Motor Activity; Overnutrition; Physical Endurance; Reboxetine; Receptors, Interleukin-1 Type I; Recognition, Psychology | 2013 |
The selective noradrenergic reuptake inhibitor reboxetine restores spatial learning deficits, biochemical changes, and hippocampal synaptic plasticity in an animal model of depression.
Topics: Acetylcholinesterase; Animals; Animals, Newborn; Antidepressive Agents; Biogenic Monoamines; Depression; Disease Models, Animal; Electric Stimulation; Female; Food Preferences; Hippocampus; In Vitro Techniques; Learning Disabilities; Male; Morpholines; Neuronal Plasticity; Rats; Rats, Wistar; Reboxetine; Spatial Learning; Swimming | 2015 |